Core Viewpoint - Mogao Co., Ltd. has announced a projected net loss for the year 2025, estimating a net profit attributable to shareholders of approximately -120 million to -100 million yuan, and a net profit excluding non-recurring gains and losses of approximately -103 million to -83 million yuan [1] Industry Summary - The domestic wine industry is undergoing a deep adjustment, with both production and consumption of wine continuing to decline, leading to lower-than-expected sales for the company [1] - The cough medicine sector is experiencing a decrease in market demand, resulting in a decline in both volume and price for the company's main product, Compound Licorice Tablets, which has negatively impacted profitability [1] - The biodegradable materials sector, while supported by national policies as an emerging industry, faces challenges due to an incomplete upstream and downstream industrial chain and pressure on product prices, leading to a decrease in the production and sales volume of PBAT compared to the previous year [1] Financial Impact - Based on the current operational status and future forecasts, the company anticipates recognizing impairment losses on certain fixed assets, inventory, and accounts receivable for the year 2025, which will affect the net profit by approximately 36 million yuan [1] - Additionally, the company plans to scrap certain productive biological assets in 2025, further impacting the financial results [1]
莫高股份:2025年全年预计净亏损10000万元—12000万元